[email protected] +44 20 8123 2220 (UK) +1 732 587 5005 (US) Contact Us | FAQ |

2017-2021 UK Molecular Diagnostics and NAT Market: Supplier Shares and Sales Forecasts

February 2017 | 4 pages | ID: U5AE82A9837EN
Venture Planning Group

US$ 1,350.00 US$ 1,500.00 -10 %

E-mail Delivery (PDF)

Download PDF Leaflet

Accepted cards
Wire Transfer
Checkout Later
Need Help? Ask a Question
This report provides:
  • Five-year sales forecasts for the UK Molecular Diagnostics market, including:
Infectious Diseases - Cancer - Forensic Testing - Genetic Diseases - Paternity Testing/HLA Typing, and other applications.
  • Sales forecasts for HIV, Hepatitis (A, B, C), Parvovirus B19 and West Nile Virus.
  • Sales and market shares for major suppliers of molecular diagnostics and NAT assays.
Contains 4 pages
THIS REPORT PROVIDES:

Fiveyear sales forecasts for the UK Molecular Diagnostics market, including:
  Infectious Diseases
  Cancer
  Forensic Testing
  Genetic Diseases
  Paternity Testing/HLA Typing, and other applications.
Sales forecasts for H4. Hepatitis (A, B, C), Parvovirus B19 and West Nile Virus.
Sales and market shares for major suppliers of molecular diagnostics and NAT assays.

LIST OF TABLES

Table 1. UK: Molecular Diagnostics Market by Major Application
Table 2. UK: Infectious Disease Blood Screening NAT Reagent Market by Assay
Table 3. UK: Molecular Diagnostics Market, Estimated Sales and Shares of Major Suppliers
Table 4. UK: HIV/Hepatitis Blood Screening NAT Market, Estimated Sales and Shares of Major Suppliers


More Publications